Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents

American Journal of Medicine

Volumn 108, Issue 1, 2000, Pages 2-8

  Cohen, Hillel W ^a   Gibson, Geoffrey ^b   Alderman, Michael H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b 1199 National Benefit Fund   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; CARDIOVASCULAR AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANXIETY; ARTICLE; CANCER; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; FEMALE; HEALTH CARE PERSONNEL; HEART INFARCTION; HOSPITALIZATION; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; HYPERTENSION; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NEW YORK CITY; RISK; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 0033977733     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00301-0     Document Type: Article

References (44)

1. Carney R.M., Rich M.W., Freeland K.E. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosomat Med. 50:1988;627-633.
2. Ahern D.K., Gorkin L., Anderson J.L., et al. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol. 66:1990;59-62.
3. Anda R., Williamson D., Jones D., et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U. S. adults. Epidemiology. 4:1993;285-294.
4. Aromaa A., Raitasalo R., Heliovaara M., et al. Depression and cardiovascular diseases. Acta Psychiatr Scand. 377:(suppl):1994;77-82.
5. Lapane K.L., Zierler S., Lasater T.M., et al. Is the use of psychotropic drugs associated with increased risk of ischemic heart disease? Epidemiology. 63:1995;376-381.
6. Barefoot J.C., Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 93:1996;1976-1980.
7. Pratt L.A., Ford D.E., Crum R.M., et al. Depression, psychotropic medication, and risk of myocardial infarction prospective data from the Baltimore ECA follow-up . Circulation. 94:1996;3123-3129.
8. Bingefors K., Isacson D., Von Knorring L., et al. Antidepressant-treated patients in ambulatory care mortality during a nine-year period after first treatment . Br J Psychiatry. 169:1996;647-654.
9. Cohen H.W., Madhavan S., Alderman M.H. Depression and myocardial infarction in treated hypertensive patients. Circulation. 96:(suppl 1):1997;375.
10. Ford D.E., Mead L.A., Chang P.P., et al. Depression is a risk factor for coronary artery disease in men the Precursors study . Arch Intern Med. 158:1998;1422-1426.
11. Physicians' Desk Reference (PDR) 1998. 1998;Medical Economics, Oradell, NJ.
12. Glassman A.H. Cardiovascular effects of antidepressant drugs updated . J Clin Psychiatry. 59:1998;13-18.
13. Treatment of depression: newer pharmacotherapies. Summary, Evidence Report/Technology Assessment: Number 7. Rockville, MD: Agency for Health Care Policy and Research; 1999. http://www.ahcpr.gov/clinic/deprsumm.htm.
14. Goode E. New and old depression drugs are found equal. New York Times. March 19, 1999: A1.
15. AHFS Drug Information 96. 1996;American Society of Health-System Pharmacists, Bethesda, MD.
16. International Classification of Diseases (ICD-9-CM), 9th Revision, Clinical Modification. 1988;Commission on Professional and Hospital Activities, Ann Arbor, Mich.
17. Cox D.R. Regression models and life tables (with discussion). J R Stat Soc. 334:1972;187-220.
18. Norusis M.J. SPSS for Windows Base System User's Guide, Release 6.0 . 1993;SPSS, Inc, Chicago.
19. Dalack G.W., Roose S.P. Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry. 51:1990;S4-S9.
20. Fielding R. Depression and acute myocardial infarction a review and reinterpretation . Soc Sci Med. 32:1991;1017-1027.
21. Carney R.M., Freedland K.E., Rich M.W., Jaffe A.S. Depression as a risk factor for cardiac events a review of possible mechanisms . Ann Behav Med. 17:1995;142-149.
22. Glassman A.H., Shapiro P.A. Depression and the course of coronary artery disease. Am J Psychiatry. 155:1998;4-11.
23. Everson S.A., Kaplan G.A., Goldberg D.E., et al. Hopelessness and 4-year progression of carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 17:1997;1490-1495.
24. Veith R.C., Lewis N., Linares O.A., et al. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry. 51:1994;411-422.
25. Siever L.J., Davis K.L. Overview toward a dysregulation hypothesis of depression . Am J Psychiatry. 42:1985;1017-1031.
26. Carney R.M., Rich M.W., teVelde A., et al. Heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res. 32:1988;159-164.
27. Breslow M.J., Ligier B. Hyperadrenergic states. Crit Care Med. 19:1991;1566-1579.
28. Markovitz J.H., Matthews K.A. Platelets and coronary heart disease potential psychophysiologic mechanism . Psychosom Med. 53:1991;643-668.
29. Musselman D.L., Tomer A., Manatunga A.K., et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 153:1996;1313-1317.
30. Musselman D.L., Evans D.L., Nemeroff M.D. The relationship of depression to cardiovascular disease. Arch Gen Psychiatry. 55:1998;580-592.
31. Preliminary report effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction . NEJM. 321:1989;406-412.
32. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. NEJM. 327:1992;227-233.
33. Roose S.P., Fouzia L., Kennedy J.S., et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA. 279:1998;287-291.
34. Williams R.B., Sherter C. Cardiac complications of tricyclic antidepressant therapy. Ann Intern Med. 74:1971;395-398.
35. Physicians' Desk Reference (PDR) 1990. 1990;Medical Economics, Oradell, NJ.
36. Glassman A.H., Bigger J.T. Cardiovascular effects of therapeutic doses of tricyclic antidepressants a review . Arch Gen Psychiatry. 38:1981;815-822.
37. Glassman A.H., Preud'homme X.A. Review of the cardiovascular effects of heterocyclic antidepressants. J Clin Psychiatry. 54:1993;16-22.
38. Glassman A.H., Rodriguez A.I., Shapiro P.A. The use of antidepressant drugs in patients with heart disease. J Clin Psychiatry. 59:1998;16-21.
39. Roose S.P., Glassman A.H. Cardiovascular effects of tricyclic antidepressants in depressed patients with and without heart disease. J Clin Psychiatry. 50:(suppl):1989;1-18.
40. Roose S.P., Devanand D., Suthers K. Depression treating the patient with comorbid cardiac disease . Geriatrics. 54:1999;20-35.
41. Skop B.P., Brown T.M. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics. 37:1996;12-16.
42. Pladevall M., Goff D.C., Nichaman M.Z., et al. An assessment of the validity of ICD code 410 to identify hospital admissions for myocardial infarction the Corpus Christi Heart Project . Int J Epidemiol. 25:1996;948-952.
43. Meier C.R., Derby L.E., Jick S.S., et al. Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA. 281:1999;427-431.
44. DeBattista C. Medical Management of Depression. 1997;EMIS, Inc, Durant, OK.